Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization

  • Haematologica. 2017 May;102(5):e170-e174. doi: 10.3324/haematol.2016.161570.
Julia Schanda  1 Chun-Wei Lee  2 Katharina Wohlan  2 Uta Müller-Kuller  1  3 Hana Kunkel  1 Isabell Quagliano-Lo Coco  1  3 Stefan Stein  1 Alexander Metz  4 Joachim Koch  1 Jörn Lausen  1 Uwe Platzbecker  5 Hind Medyouf  1 Holger Gohlke  4 Michael Heuser  2 Matthias Eder  2 Manuel Grez  6 Michaela Scherr  2 Christian Wichmann  1  7
Affiliations
  • 1. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • 2. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany.
  • 3. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 4. Institute for Pharmaceutical and Medicinal Chemistry, Department of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Germany.
  • 5. Department of Hematology, Medical Clinic and Polyclinic I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • 6. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany [email protected].
  • 7. Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich, Germany.
Products